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ABSTRACT: Tricyclic carbazole is an important scaffold in
many naturally occurring metabolites, as well as valuable
building blocks. Here we report the reconstitution of the ring
A formation of the bacterial neocarazostatin A carbazole
metabolite. We provide evidence of the involvement of two
unusual aromatic polyketide proteins. This finding suggests
how new enzymatic activities can be recruited to specific
pathways to expand biosynthetic capacities. Finally, we
leveraged our bioinformatics survey to identify the untapped
capacity of carbazole biosynthesis.
Neocarazostatin A 1 is a bacterial metabolite first isolatedfrom the culture of Streptomyces sp. GP38 in 1991 and
later from the soil bacterium Streptomyces sp. MA37, which
consist of a tricyclic nucleus with two benzene rings (rings A
and C) fused with a pyrrol ring (ring B) (Figure 1).1,2 This
compound exhibits potent antioxidant activity and displays
considerably lower IC50 values for inhibition of lipid
peroxidation than those of the free radical scavengers, such
as butylhydroxytoluene and the drug flunarizine.2 There have
been considerable interests among medicinal chemists to
develop 1 due to its pharmacological potential. Neo-
carazostatin A 1 belongs to a group of simple carbazole
alkaloids (CAs) with aliphatic side chains. Considering the
oxidative status of ring A, this group of CAs can be categorized
into four subgroups: indole-fused dihydroxyl-type CAs
including 1 as a representative, indole-fused monohydroxyl-
type CAs such as carazostatin, indole-fused ortho-quinone CAs
such as carquinonstatin A, and nonaromatic type CA (Figure
1).
In our previous studies, we have delineated the functions of
five key enzymes encoded in the biosynthetic gene cluster
(BGC) of 1 (nzs), including the phytoene-synthase-like
prenyltransferase NzsG and the P450 hydroxylase NzsA,1 a
thiamine diphosphate-dependent enzyme NzsH,3 a free-
standing acyl carrier protein (ACP) NzsE and a classical β-
ketoacyl−acyl carrier protein synthase III NzsF.4
Here, we demonstrated that in vitro reconstitution of NzsJ
and I, together with NzsH and other necessary substrates and
cofactors, enables the formation of the A ring of 1, which is
spontaneously oxidized into ortho quinone-containing carba-
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Figure 1. Representatives of four subgroups of bacterial tricyclic
carbazole alkaloids.
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zole, a similar observation discovered by Kobayashi and co-
workers in parallel to our study.5 Isotopic labeling studies
demonstrate that one of the oxygens in the A ring is derived
from water. Moreover, comparative genomics and a global
network analysis of sequence similarity of nzsH, J, and I
suggested that these gene homologues are clustered, and the
occurrence of these BGCs in the bacterial kingdom suggests
important biological functions in these organisms.
Our previous studies suggested that both nzsJ and nzsI genes
are essential for the production of 1, and no obvious
intermediates were accumulated in both nzsJ and I knockout
mutants.1 Bioinformatics analysis suggested that NzsJ is a
putative FabH-like 3-ketoacyl-ACP synthase (KAS) III and
that NzsI is a structural homologue of aromatase/cyclases
(ARO/CYCs) that involve type II aromatic polyketide (PKS
II) biosynthesis, strongly suggesting that Streptomyces sp.
MA37 recruits new enzyme activities from the PKS II assembly
line to the CA biosynthetic gene clusters to enable the
evolution of biosynthetic capacity. During the manuscript
preparation, reconstitution of the biosynthetic pathway of
carquinostatin A, a structural homologue of 1, was reported5
with the structural insights of one of the key biosynthetic
enzymes, CqsB2, the homologue of NzsI with high sequence
identity (80%).
In this study, we provide a full account of our work and
show that NzsJ and NzsI catalyze the formation of the A ring
of 1. To this end, we set out in vitro enzymatic assays.
Overexpression of NzsJ and NzsI in S. lividans allowed us to
isolate and purify the recombinant protein to near homoge-
neity with the estimated molecular weight of 35 kDa and 28
kDa, respectively, as determined by SDS-PAGE analysis
(Figure S1). Considering the instability of α-hydroxyl acyloin
3 from NzsH (the structure of 3 has been revised here
compared to our previous structural interpretation3), we first
performed a one-pot reaction by incubating NzsJ (1 μM) with
the enzymatic systems of NzsH and NzsE we’ve established
before to generate the acyloin and 3-hydroxybutyryl-NzsE in
situ, respectively; two new compounds with mass-to-charge
ratios (m/z) of 290.1382 were formed as observed in the LC-
HR-ESIMS analysis. N-Acetylcysteamine (SNAC) is com-
monly used as a simplified synthetic mimic of the reactive
biosynthetic intermediates, such as acyl-ACP in the bio-
synthetic studies.6,7 To isolate new compounds for structural
elucidation, we chemically prepared R-3-hydroxybutyryl-SNAC
(Figures S2−4). Upon incubation of NzsJ with R-3-
hydroxybutyryl-SNAC and the enzymatic system of NzsH,
the target molecules with identical molecular weights and UV
absorption but different retention times (compound 5 and 6)
were observed in the HR-ESIMS and HPLC analyses (Figure
2A, Figure S5). Interpretation of NMR spectral and HR-
ESIMS data suggested that 5 is likely to be an indole-acetyl
ester despite the presence of the impurity (Figures S6−8).
Compound 6 was proposed to be the isomer of 5.
To further confirm the structures of 5 and 6, we added
NaBH4 into the enzymatic mixture at the end of the assay,
resulting in the appearance of two new ions, 7 and 8, with both
of which have m/z of 292.1540 as observed in the HR-ESIMS
(Figure S9), further confirming the presence of only one
ketone functional group. HR-ESLMS data for compounds 7
and 8 indicated a molecular formula of C16H21NO4, suggesting
7 degrees of unsaturation. The structure of 8 was proposed to
be the reduced product of 5 by the interpretation of NMR
spectral data (Figures S10−13, Table S1) coupled with
theoretical calculations (Figures S14−16). Compound 7 was
deduced to be the isomer of 8.
Analysis of the structures of 5, 6 and their derivatives, 7 and
8, led to speculation that 5 or 6 may be the substrate of NzsI.
Surprisingly, an enzymatic assay of NzsI with the isolated 5 and
6 resulted in no new product, strongly suggesting that 5 and 6
were rearranged enzymatic products, a similar observation of
recent parallel report.5
This led us to speculate that 4 is the bonafide product of
NzsJ that underwent a spontaneous α-ketol rearrangement
reaction (Figure 2B). Such a rearrangement is also observed in
the interconversion from the dibenzo[b]fluorene skeleton to a
benzo[g]chromene in the synthetic experiments8 and the
biogenetic interconversions between prekinamycin and iso-
prekinamycin9 (Figure S17). Density functional theory (DFT)
calculations also confirmed that the structure of 4 has a higher
energy than that of 5 or 6 (Table S2). It is noteworthy that no
ions with a 4 Da increase were observed, strongly suggesting
that the predicted intermediate 4 was not accumulated and
underwent immediate rearrangement.
To investigate the roles of both NzsJ and NzsI, we
performed a one-pot reaction of NzsI in the presence of
NzsJ, 3-hydroxybutyryl-SNAC, and the NzsH system. A new
product (9) was generated with m/z of 270.1125, as observed
Figure 2. Functional dissection of NzsJ. (A) HPLC analysis of the
one-pot enzymatic reaction catalyzed by NzsH/J. (i) Control reaction
using pyruvate, indol-3-pyruvate (2), and boiled NzsH/J; (ii) control
reaction using pyruvate, 2, 3-hydroxybutyryl-SNAC, and boiled NzsJ;
(iii−vi) time course of the NzsH/J one-pot reactions containing
pyruvate, 2, 3-hydroxybutyryl-SNAC, NzsH, and NzsJ, terminated at
10, 30, 60, and 120 min, respectively. The UV absorption was
monitored at 280 nm. It is noteworthy that three HPLC peaks at the
retention times of 17.5−18.5 min were putative byproducts (bp)
during the biotransformation. The bp1 has the m/z of 378.1576 as
observed in HR-ESIMS. However, we were unable to determine the
m/z of bp2 and bp3. (B) The proposed reaction of NzsJ.
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in the HR-ESIMS analysis (Figure 3A, Figure S18). In a
control assay with boiled NzsI and in other control assays
lacking either the NzsH system or NzsJ or SNAC substrate, the
formation of 9 was not observed.
To confirm the structure of 9, a large-scale biotransforma-
tion reaction was carried out to afford the isolation of 9 (8
mg). The inspection of 1D and 2D NMR spectral data
demonstrated that 9 is an ortho-quinone carbazole (Figures
S19−22). Intriguingly, bioinformatics analysis suggested that
NzsI is not an oxidative enzyme, leading us to speculate 10 is
the bona fide enzymatic product of NzsI but was oxidized
spontaneously (Figure S23A). The presence of dithiothreitol
(DTT, 1 mM) in the biotransformation of NzsH/J/I indeed
extended the existence of the ortho-dihydroxyl compounds 10
as observed in HPLC and HR-MS analyses (Figure S23B,C).
This led us to propose that NzsI may install the hydroxyl
group at the C4 of 4 from one water molecule. To verify this
hypothesis, we carried out the biotransformation using
isotopically enriched water. An assay of NzsI with the
substrates in the buffer system enriched with H2
18O (15%)
was performed. Indeed, isotopically enriched 9a ([M+2]+:
18%) was observed (Figure 4A,B), as determined by HR-
ESIMS analysis and by comparison with the MS pattern of 9
(Figure S24). To further confirm that the hydroxyl group is
indeed located at the C4 position in the A ring, a large-scale
biotransformation reaction was performed to afford the
isolation the mixture of 9 and isotopically enriched 9a. The
inspection of 13C{1H} NMR of the resultant product
demonstrated the 18O-induced isotope shifts at the ketone of
C4 of 9 (Figure 4C, Figure S25). The magnitude of this
isotope shift is 0.04 ppm for the C4 attached to 18O, consistent
with the previous observation.10
Taken together, these experiments confirmed that NzsI
utilizes the acid−base chemistry to catalyze the cyclization,
followed by nucleophilic aromatization of water to afford the
catechol moiety of carbazole metabolites, strongly suggesting
that NzsI is a new type of cyclases/aromatases.
Based on the oxygen pattern in the A ring, this group of
bacterial carbazole metabolites can be categorized into four
subgroups: monohydroxyl type, dihydroxyl type, ortho-
quinone type, and nonaromatic type (Figure S26). We propose
that the A ring of the carbazole is assembled by NzsH, NzsJ,
and NzsI or corresponding enzyme homologues. The assembly
of the A ring is initiated by the carboligation of 2 and pyruvate
in a reaction catalyzed by NzsH or its homologues to afford the
corresponding α-keto acid 3. Depending on the bioavailability
of the Acyl-CoA species in the producing strains, an
unidentified acyltransferase will catalyze the transthiolation
reaction to load Acyl-CoA into NzsE or its homologues to
generate acyl-tethered thioesters. NzsJ or its homologues will
utilize both 3 and acyl-tethered thioesters to mediate the
decarboxylation-driven retro-aldol reaction to generate the
intermediate, followed by cyclization via abstraction of the
acidic proton at the C4 position, spontaneous dehydration, and
water-based nucleophilic aromatization to yield the catechol
motif. Methylation or transamination followed by acylation
would result in dihydroxyl type carbazoles. Reduction on the
key catechol-type intermediate will generate the nonaromatic
type. Currently, only one metabolite without an aromatic
feature in the A ring has been isolated from Streptomyces sp.
BCC26924.11 If a reduction is involved in the NzsI-mediated
reaction, the hydride-based nucleophilic aromatization would
afford the monohydroxyl type of carbazole metabolites.
The presence of NzsI homologues in the bacterial kingdom
was investigated. A blast search using NzsI as the query in the
NCBI database allowed identification of a collection of NzsI-
Figure 3. Functional dissection of NzsI. (A) HPLC analysis of the
one-pot enzymatic reactions catalyzed by NzsH/I/J. (i) Control
reaction using pyruvate, 2, and boiled NzsH/I/J; (ii) control reaction
using pyruvate, 2, 3-hydroxybutyryl-SNAC, NzsH, and boiled NzsJ/I;
(iii) NzsH/J one-pot reactions plus boiled NzsI for 30 min of
incubation. (iv) NzsI was added into reaction iii and incubated for
another 30 min; (v−vii) time course of one-pot reactions containing
NzsH/I/J, pyruvate, 2, and 3-hydroxybutyryl-SNAC, terminated at
30, 60, and 120 min, respectively. The tiny peak following 9
corresponds to a tautomer (10 or 10a). The UV absorption was
monitored at 280 nm. (B) The proposed reaction of NzsI.
Figure 4. Isotope-labeling strategy and the representative mass
chromatograms and NMR spectra. (A) Schematic depiction of the
H2
18O isotope substitution. (B) LC-HR-ESIMS analysis of the
enzymatic mixture of the NzsH/I/J one-pot reaction. Extracted ion
chromatograms representing the off-labeled 9 and on-labeled 9a. BP:
base peak mass. AA: peak area. (C) 18O causes an upfield shift (0.04
ppm) of attached C4 NMR signals in compound 9a.
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like homologues that share a high amino acid sequence identity
(43%−80%). The corresponding genes are found in the
genome of microorganisms, including the Gram-positive
actinomycetes, the well-studied S. cattleya, the Gram-negative
bacteria including the thermophilic bacterium Legionella
gratiana, the soil-dwelling myxobacterium Sorangium cellosum,
and the cyanobacterium Scytonema tolypothrichoides (Figure 5,
Table S3). Strikingly, adjacent to these nzsI-like genes are
nzsH-like and nzsJ-like genes in some cases (Table S3). In silico
analysis also indicated that these NzsJ-like open reading frames
(ORFs) also share a high amino acid sequence identity (24%−
73%) to NzsJ (Table S3). Furthermore, MEME prediction12
demonstrated that all of the NzsI-like ORFs share highly
conserved motifs with NzsI (Figure S27), whereas all of the
NzsJ-like ORFs share the conserved catalytic triad C−H−N
with NzsJ and other KAS III proteins (Figure S28), suggesting
that these ORFs should process the same chemical reactions as
those for NzsI and NzsJ, respectively. However, analysis of the
genes in the close proximity of these orfs suggested that these
identified gene clusters encode completely different sets of
auxiliary enzymes that were predicted to modify the CA ring
system or the fatty acid chains. It is likely that these strains
have the potential to produce not-yet-discovered new CA-like
metabolites.
In conclusion, in vitro reconstitution of two unusual
enzymes, NzsJ and NzsI, together with NzsH and other
necessary substrates and cofactors, demonstrate the assembly
of the A ring moiety of the bacterial carbazole metabolite 1.
Isotopic labeling studies demonstrated that the hydroxyl group
at C4 position of the A ring is originated from one water
molecule. Bioinformatics analysis further uncovered that the
homologues of NzsI are widespread in bacteria associated with
NzsH and NzsJ homologues, suggesting that carbazole-type
metabolites are ubiquitous in the bacterial kingdom.
■ EXPERIMENTAL SECTION
General Materials and Methods. All chemicals and solvents
were obtained from Sigma-Aldrich except where noted. Oligonucleo-
tide primers were synthesized by GenScript (Nanjing, China). The
DNA sequencing of PCR products and all constructive plasmids was
performed by TSINGKE Biological Technology (Wuhan, China).
Restriction endonucleases and T4 ligase were purchased from NEB.
High-fidelity DNA polymerase KOD was purchased from TOYABO.
A typical PCR reaction contained 10−100 ng of the DNA template,
0.5 μM of each primer, 2 μL of 10× KOD buffer, and 0.3 μL of high-
fidelity KOD polymerase. Thermocycling was carried out in Bio-Rad
C1000 thermocycler. E. coli DH10B was used as a cloning host. E. coli
ET12567/pUZ8002 was used for intergeneric conjugation between E.
coli and Streptomyces. E. coli DH10B, and E. coli ET12567/pUZ8002
were cultured in Luria−Bertani (LB, tryptone 1%, yeast extract 0.5%,
NaCl 1%) or LB agar medium at 37 °C. S. lividans TK24 and S.
lividans 1326 were grown on MS agar plates (soybean 2%, D-mannitol
2%, agar 2%) at 28 °C for sporulation and in the YEME medium
(glucose 1%, tryptone 0.5%, yeast extract 0.3%, malt extract 0.3%,
sucrose 10.3%) for protein overexpression. The MS medium with
additional 10 mM MgCl2 was used for intergeneric conjugation.
HPLC analysis was carried out on a Shimadzu (Kyoto, Japan) HPLC
instrument equipped with a degasser (DGU-20A3), an autosampler
(SIL-20A), a column oven (CTO-20A) and two pumps (LC-20AT),
and Phenomenex columns (C18, 5 μm) 250 mm × 4.6 mm. HPLC
conditions for analysis of the one-pot reaction: the C18 column was
pre-equilibrated with 20% B and developed at a flow rate of 0.8 mL/
min, 0−20 min, a linear gradient from 80% A to 20% A; 20−25 min, a
linear gradient from 80% A to5% A; 25−27 min, constant with 5% A;
27−30 min, a linear gradient to 80% A; 30−35 min, constant with
80% A; UV absorption was monitored at 280 nm. Solvent A was 0.1%
formic acid in H2O, and solvent B was 0.1% formic acid in CH3CN.
HR-ESI-MS analysis was carried out in the positive ion mode by using
a Thermo Scientific LTQ XL Orbitrap mass spectrometer equipped
with a Thermo Scientific Accela 600 pump (Thermo Fisher Scientific
Inc.). Each of the LC conditions were described as above. All MS
analysis parameters were as follows: 45 V capillary voltage, 45 °C
capillary temperature, auxiliary gas flow rate 10 arbitrary units, sheath
gas flow rate 40 arbitrary units, 3.5 kV spray voltage, and 50−1000
Amu mass range (maximum resolution 30 000).
Chemical Synthesis of 3-Hydroxybutyryl-SNAC. 3-Hydrox-
ybutyryl-SNAC was synthesized as a simplified mimic of the reactive
biosynthetic intermediate, which can be recognized by NzsJ in vitro.
(R)-(−)-3-Hydroxybutanoyl sodium salt (630 mg, 5 mmol) was
added to a solution of CF3SO3H (750 mg, 5 mmol) in 25 mL of
dichloromethane (DCM), and the mixture was stirred at 0 °C for 1 h.
Then the N-acetylcysteamine (NAC, 500 mg, 4.2 mmol, 1 equiv), N-
(3-(dimethylamino)propyl)-N′-ethylcarbodiimide hydrochloride
(EDCI, 800 mg, 1 equiv), and N,N-dimethylpyridin-4-amine
(DMAP, 52 mg, 0.1 equiv) were sequentially added. The reaction
mixture was stirred at 22 °C for 16 h. After removing the solid by
filtration, the filtrate was poured into 10 mL of cold water and
extracted with ethyl acetate. Then the ethyl acetate layer was
concentrated to dryness. The residue was dissolved in 2 mL DCM,
and the reaction was monitored by TLC (DCM/methanol = 15/1).
The solvent was removed, and the residue was purified on a silica gel
flash column (DCM/methanol = 100/1) to yield 3-hydroxybutyryl-
SNAC (0.12 g, 12%): 1H NMR, δH (CDCl3, 400 MHz) 1.21 (d, J =
6.3 Hz, 3H), 1.95 (s, 3H), 2.70 (m, 2H), 3.03 (m, 2H), 3.43 (m, 2H),
4.24 (m, 1H); 13C{1H} NMR, δC (101 MHz, CDCl3) 199.6 (CO, C-
7), 170.8 (CO, C-2), 65.3 (COH, C-9), 52.7 (CH2, C-8), 39.5 (CH2,
C-4), 29.0 (CH2, C-5), 23.4 (CH3, C-1), 22.9 (CH3, C-10); HR-
ESIMS m/z [M + H] + calcd for C8H16NO3S
+ 206.0845, found
206.0843.
Construction of NzsJ and NzsI Overexpression Plasmid. The
genes nzsJ were amplified from S. sp. MA37 genomic DNA using the
primer pair His-NzsJ-F and His-NzsJ-R (Table S4) by high-fidelity
PCR. The PCR-amplified products were purified and then cloned into
a NdeI/HindIII cleaved expression vector pWDYHS01 by using an
InFusion HD cloning kit (Clontech) to yield pWDY900. pWDY900
was then transformed into S. lividans TK24, and the resulting colonies
were selected by the aac(3)IV resistant marker and confirmed by PCR
to obtain the recombinant strain WDY900. The strain WDY900 was
used for overexpression of the His-tagged NzsJ in Streptomyces. The
genes nzsI were PCR amplified from MA37 genomic DNA using the
primers His-NzsJ-F/R and His-NzsI-F/R (Table S5). The PCR
products were purified from an agarose gel and then cloned into an
NdeI/HindIII linearized vector, pWDYHS01, using an InFusion HD
cloning kit (Clontech). The ligation mixture was transformed into
competent E. coli DH10B cells by heat shock. The recovery culture
was plated on LB agar containing apramaycin (50 μg/mL) to screen
Figure 5. Sequence similarity network analysis of homologues of
NzsH, NzsI, and NzsJ. Each node in the network represents a
homologous protein, and each edge represents the pairwise
connection between two proteins with a blastP E value <1 × 10−10.
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the positive clones, and then the positive assembly was confirmed by
digestion and sequencing.
Expression and Purification of NzsI and NzsJ. E. coli
ET12567/pUZ8002 was first transformed with the verified plasmids
and then conducted general intergeneric conjugation with the S.
lividans TK24 or 1326 to yield the protein overexpressed strain
WDY900 and WDY901 (Table S6), respectively. The overexpression
strain WDY900 or WDY901 was inoculated into 50 mL of the TSBY
medium supplemented with 50 μg/mL apramycin and grown at 28 °C
with shaking at 200 rpm for 2 days. The preculture was transferred to
500 mL of the YEME medium supplemented with 50 μg/mL
apramycin at 28 °C with shaking at 200 rpm for 2 days. Protein
expression was induced with the addition of 0.5 mM (final
concentration) thiostrepton. After an additional 60 h of incubation,
the cells were harvested by centrifugation at 5000g for 20 min at 4 °C.
The cell pellets collected by centrifugation were resuspended in ice-
cold lysis buffer (20 mM Tris-HCl, 300 mM NaCl, 10 mM imidazole,
and 10% (v/v) glycerol, pH 8.0) and disrupted by a high-pressure
homogenizer machine (Avestin, EmulsiFlex-C3). Cell debris was
removed via centrifugation (4 °C, 12 000g, 30 min), and the
supernatant was filtered before loading onto a 5 mL HisTrapHP
column (GE Healthcare). The HisTrapHP column was washed by six
concentration-step elution buffers, with 15 mL for each step (20 mM
Tris-HCl, 300 mM NaCl, 10% (v/v) glycerol, along with 20 mM, 50
mM, 100 mM, 150 mM, 200 mM, or 300 mM imidazole, pH 8.0).
The elution fractions were checked by SDS-PAGE, and then the
desired elution fractions were concentrated using centrifugal filter
units (Milipore, 10 000 MWCO, Merck). The concentrated protein
solution was subsequently desalted using a PD-10 column (GE
Healthcare) pre-equilibrated with the elution buffer (20 mM Tris-
HCl, 100 mM NaCl, and 10% (v/v) glycerol, pH 8.0). The desalted
effluent was centrifuged again and was then aliquoted, flash-frozen in
liquid nitrogen, and stored at −80 °C. SDS-PAGE and spectrophoto-
metric analysis (Bradford assay kit, Promega, BSA used as standard,
absorbance at 595 nm) were used to check the purity and
concentration of the protein.
In Vitro Enzymatic Assay of the NzsH/J One-Pot Reaction.
The NzsH/J one-pot reaction was performed by incubating 1 μM
NzsJ and 1 mM 3-hydroxybutyryl-SNAC with the enzyme systems of
NzsH. The reaction mixture was incubated at 30 °C for the scheduled
time and quenched by an equal volume of ice-cold methanol. The
clarified supernatant was obtained by centrifugation at 13 000g for 30
min and then subjected to HPLC and HR-ESIMS analysis. The NzsH
and boiled NzsH/J added mixture were used as control reactions.
In Vitro Enzymatic Assay of the NzsH/J/I One-Pot Reaction.
The NzsH/J/I one-pot reaction was performed by adding 1 μM NzsI
in the mixture of the NzsH/J one-pot system, as described above. The
mixture was incubated at 30 °C for the scheduled time and quenched
by an equal volume of precooled MeOH. The clarified supernatant
was obtained by centrifugation at 13 000g for 30 min and then
subjected to HPLC and HR-ESIMS analysis. The NzsH, boiled
NzsH/J/I added, and NzsH/J one-pot mixture were all used as
control reactions. The NzsH/J/I reactions with DTT were performed
by adding 1 mM DTT in the one-pot system.
Isotopic Labeling Experiments. To verify that the oxygen
attached to C4 of 9 (1-(2-hydroxypropyl)-2-methyl-carbazole-
3,4(9H)-dione) was derived from water, the NzsH/J/I one-pot
reaction was performed by incorporating 15% 18O-water. The labeled
compound 9a was obtained with theoretically consistent mass data on
the HR-ESIMS analysis. We then scaled up the enzymatic reaction to
50 mL with a 15% incorporation ratio of 18O-water in order to
accumulate 9a for 13C{1H} NMR spectra analysis. The resulting
incorporation ratio was calculated by integrating the peak area of 9a
on the mass chromatogram as follows: 18O incorporation ratio % =
peak area 9a/(peak area 9a + peak area 9) × 100.
Structural Characterization of Reaction Products. The
compound 8 (3,5-dihydroxyhexan-2-yl 2-(1H-indol-3-yl) acetate)
was isolated and purified from the enzymatic reaction, evaporated
to dryness, and resolved in CD3OD for structure characterization on
NMR analysis. The compound 9 was isolated and purified from the
enzymatic reaction, evaporated to dryness, and resolved in DMSO-d6
for structure characterization on NMR analysis. The NMR data of the
compound was collected on a Bruker Avance 600 MHz NMR
spectrometer.
Compound 8: 1H NMR, δH (600 MHz, CD3OD), 3.89 (m, H-1),
1.58 (m, H-2a), 1.36 (m, H-2b), 3.44 (m, H-3), 3.49 (q, H-4), 3.67
(s, H-6), 7.41 (d, H-8), 6.91 (dd, J = 7.7, 8.1 Hz, H-9), 6.99 (dd, J =
7.7, 8.0 Hz, H-10), 7.25 (d, J = 8.0 Hz, H-8), 7.06 (s, H-13), 1.06 (d, J
= 6.4 Hz, H-14), 1.09 (d, J = 6.1 Hz, H-15); HR-ESIMS m/z [M +
H] + calcd for C16H22NO4
+ 292.1543, found 292.1540.
Compound 9: 1H NMR, δH (600 MHz, DMSO-d6), 7.83−7.86 (m,
H-5), 7.50−7.55 (m, H-4), 7.22 (dd, J = 5.6, 2.9 Hz, H-6, H-7), 3.97
(q, J = 6.0 Hz, H-11), 2.79 (m, CH2), 1.93 (s, CH3), 1.24 (d, J = 6.0
Hz, CH3);
13C{1H} NMR, δC (150 MHz, DMSO-d6), 183.5 (CO, C-
3), 172.54 (CO, C-4), 146.3 (C, C-9a), 139.6 (C, C-1), 136.9 (C, C-
8a), 134.5 (C, C-2), 125.5 (C, C-4b), 123.9 (C, C-6), 123.7 (C, C-7),
120.0 (C, C-5), 113.3 (C, C-8), 110.7 (C, C-4a), 65.7 (CH, C-11),
37.6 (CH2, C-10), 23.5 (CH3, C-12), 12.0 (CH3, C-13); HR-ESIMS
m/z [M + H]+ calcd for C16H16NO3
+ 270.1125, found 270.1125.
Compound 9a: 13C{1H} NMR, δC (150 MHz, DMSO-d6), 184.0
(CO, C-3), 172.54 and 172.50 (CO and C18O, C-4), 147.1 (C, C-9a),
140.2 (C, C-1), 137.8 (C, C-8a), 134.6 (C, C-2), 126.0 (C, C-4b),
123.9 (C, C-6), 123.8 (C, C-7), 120.2 (C, C-5), 113.8 (C, C-8), 110.9
(C, C-4a), 66.0 (CH, C-11), 37.9 (CH2, C-10), 23.7 (CH3, C-12),
12.2 (CH3, C-13); HR-ESIMS m/z [M + H]
+ calcd for
C16H16NO2
18O+ 272.1167, found 272.1166.
Sequence Similarity Network Analysis. The homologues of
NzsH, NzsI, and NzsJ from different microorganisms were obtained
by blastp search by using NzsH, NzsI, and NzsJ as query sequences,
respectively. Adjacent to these nzsI-like genes, there are nzsH-like and
nzsJ-like genes located in some gene clusters (Table S3). The proteins
of these nzsI-like, nzsH-like, and nzsJ-like genes were selected for
further network analysis. The network was constructed by an all-by-all
blastp comparison of each sequence against each other sequence and
was generated using the EFI-Enzyme Similarity Tool.13 Sequence
similarity networks were visualized in Cytoscape 3.6.114 to illustrate
the distribution of NzsH, NzsI, and NzsJ cluster in microorganisms.
The nodes were arranged by using the yFiles organic layout with
manual adjustment. Accession numbers were listed in Table S3. The
alignment identity of NzsI homologues was visualized with a heat
map.
Sequence Alignment Analysis. The multiple sequence align-
ment of NzsJ, KAS III proteins, KAS III-like proteins, and NzsJ
homologues were performed by ClustalX215 and visualized by ESPript
3.0.16 To determine conserved motifs in 20 NzsI-like sequences
analyzed by blast and cluster mining, MEME12 search was performed
with the following parameters: mod = zoops, nmotifs = 30, minw = 6,
and maxwidth = 50.
Computational Methods for Theoretical Calculation. HR-
ESIMS data for compound 8 indicated a molecular formula of
C16H21NO4, suggesting 7 degrees of unsaturation in the structure of
compound 8. Detailed analysis of 1H, 13C{1H}, COSY, HSQC, and
HMBC data enabled the construction of the spin systems. A good
correlation (r2 = 0.9984) of predicted 13C NMR versus experimental
13C{1H} NMR data suggested the structure is possibly correct.17 1D
and 2D NMR data were inputted to the ACD/Laboratories Structure
Elucidator and all possible structures calculated within an average
difference of 4 ppm difference between calculated and experimental
chemical shifts, yielding 48 possible structures. The top 5 calculated
structures were calculated by the Structure Elucidator with 13C
chemical shift deviations between the experimental and the predicted
HOSE-code (dA),18 Artificial Neural Net (dN), and Incremental
Method. After ranking using the Neural Network Match Factor, the
resulted number one candidate is inconsistent with the predicted
structure of 8.
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